Corrigendum to “MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways” (MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways (2013) 337(2) (226–236), (S0304383513003765), (10.1016/j.canlet.2013.05.007));MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathor2

Cancer Letters

Volumn 337, Issue 2, 2013, Pages 226-236

  Bao, Longlong ^a   Yan, Yan ^a   Xu, Can ^b   Ji, Weidan ^a   Shen, Shuwen ^a   Xu, Gaoya ^a   Zeng, Yong ^a   Sun, Bin ^a   Qian, Haihua ^a   Chen, Lei ^a   Wu, Mengchao ^a   Su, Changqing ^a   Chen, Jie ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

AKT; EMT; Epithelial mesenchymal transition; ERK; HCC; Hepatocellular carcinoma; HSPG; HSulf 1; Human sulfatase 1; MicroRNA; QRT PCR; Signaling

Indexed keywords

MICRORNA 21; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; SULFATASE; SULFATASE 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR PROMOTION; TUMOR XENOGRAFT; UPREGULATION;

EID: 84880506510     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2019.12.034     Document Type: Erratum

References (39)

1. Sanchez-Tillo E., Liu Y., de Barrios O., Siles L., Fanlo L., Cuatrecasas M., Darling D.S., Dean D.C., Castells A., Postigo A. EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness. Cell. Mol. Life Sci. 2012, 69:3429-3456.
2. Han M., Liu M., Wang Y., Chen X., Xu J., Sun Y., Zhao L., Qu H., Fan Y., Wu C. Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN. PLoS One 2012, 7:e39520.
3. Braun J., Hoang-Vu C., Dralle H., Huttelmaier S. Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas. Oncogene 2010, 29:4237-4244.
4. Han M., Liu M., Wang Y., Mo Z., Bi X., Liu Z., Fan Y., Chen X., Wu C. Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells. Mol. Cell. Biochem. 2012, 363:427-436.
5. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
6. Bonnomet A., Brysse A., Tachsidis A., Waltham M., Thompson E.W., Polette M., Gilles C. Epithelial-to-mesenchymal transitions and circulating tumor cells. J. Mammary Gland Biol. Neoplasia 2010, 15:261-273.
7. Baum B., Georgiou M. Dynamics of adherens junctions in epithelial establishment, maintenance, and remodeling. J. Cell Biol. 2011, 192:907-917.
8. Polakis P. Wnt signaling and cancer. Genes Dev. 2000, 14:1837-1851.
9. Thiery J.P., Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 2006, 7:131-142.
10. Bullock M.D., Sayan A.E., Packham G.K., Mirnezami A.H. MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression. Biol. Cell 2012, 104:3-12.
11. Oishi N., Kumar M.R., Roessler S., Ji J., Forgues M., Budhu A., Zhao X., Andersen J.B., Ye Q.H., Jia H.L., Yamashita T., Woo H.G., Kim Y.J., Kaneko S., Tang Z.Y., Thorgeirsson S.S., Wang X.W. Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma. Hepatology 2012, 56:1792-1803.
12. Choi S.S., Diehl A.M. Epithelial-to-mesenchymal transitions in the liver. Hepatology 2009, 50:2007-2013.
13. Bao B., Wang Z., Ali S., Kong D., Li Y., Ahmad A., Banerjee S., Azmi A.S., Miele L., Sarkar F.H. Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. Cancer Lett. 2011, 307:26-36.
14. Meng F., Henson R., Wehbe-Janek H., Ghoshal K., Jacob S.T., Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007, 133:647-658.
15. Zhu S., Si M.L., Wu H., Mo Y.Y. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J. Biol. Chem. 2007, 282:14328-14336.
16. Asangani I.A., Rasheed S.A., Nikolova D.A., Leupold J.H., Colburn N.H., Post S., Allgayer H. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008, 27:2128-2136.
17. Zhu S., Wu H., Wu F., Nie D., Sheng S., Mo Y.Y. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 2008, 18:350-359.
18. Gabriely G., Wurdinger T., Kesari S., Esau C.C., Burchard J., Linsley P.S., Krichevsky A.M. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol. Cell. Biol. 2008, 28:5369-5380.
19. Blanco-Aparicio C., Renner O., Leal J.F., Carnero A. PTEN, more than the AKT pathway. Carcinogenesis 2007, 28:1379-1386.
20. Weng L.P., Smith W.M., Brown J.L., Eng C. PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model. Hum. Mol. Genet. 2001, 10:605-616.
21. Liu L.Z., Li C., Chen Q., Jing Y., Carpenter R., Jiang Y., Kung H.F., Lai L., Jiang B.H. MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1alpha expression. PLoS One 2011, 6:e19139.
22. Ji W., Yang J., Wang D., Cao L., Tan W., Qian H., Sun B., Qian Q., Yin Z., Wu M., Su C. HSulf-1 gene exhibits anticancer efficacy through negatively regulating VEGFR-2 signaling in human cancers. PLoS One 2011, 6:e23274.
23. Khurana A., Liu P., Mellone P., Lorenzon L., Vincenzi B., Datta K., Yang B., Linhardt R.J., Lingle W., Chien J., Baldi A., Shridhar V. HSulf-1 modulates FGF2- and hypoxia-mediated migration and invasion of breast cancer cells. Cancer Res. 2011, 71:152-2161.
24. Zhang H., Newman D.R., Sannes P.L. HSULF-1 inhibits ERK and AKT signaling and decreases cell viability in vitro in human lung epithelial cells. Respir. Res. 2012, 13:69.
25. Liu H., Fu X., Ji W., Liu K., Bao L., Yan Y., Wu M., Yang J., Su C. Human sulfatase-1 inhibits the migration and proliferation of SMMC-7721 hepatocellular carcinoma cells by downregulating the growth factor signaling. Hepatol. Res. 2013, 43:516-525.
26. Kim H.A., Kim K.J., Seo K.H., Lee H.K., Im S.Y. PTEN/MAPK pathways play a key role in platelet-activating factor-induced experimental pulmonary tumor metastasis. FEBS Lett. 2012, 586:4296-4302.
27. Ruan Z.P., Xu R., Lv Y., Tian T., Wang W.J., Guo H., Nan K.J. PTEN enhances the sensitivity of human hepatocellular carcinoma cells to sorafenib. Oncol. Res. 2012, 20:113-121.
28. Chetram M.A., Hinton C.V. PTEN regulation of ERK1/2 signaling in cancer. J. Recep. Signal Transduct. Res. 2012, 32:190-195.
29. Zhang J.G., Wang J.J., Zhao F., Liu Q., Jiang K., Yang G.H. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Clin. Chim. Acta 2010, 411:846-852.
30. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
31. Xia H., Hui K.M. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics. Cancer Gene Ther. 2012, 19:723-730.
32. Li J., Mo M.L., Chen Z., Yang J., Li Q.S., Wang D.J., Zhang H., Ye Y.J., Li H.L., Zhang F., Zhou H.M. HSulf-1 inhibits cell proliferation and invasion in human gastric cancer. Cancer Sci. 2011, 102:1815-1821.
33. Zhang Y., Fang L., Zhang Q., Zheng Q., Tong J., Fu X., Jiang X., Su C., Zheng J. An oncolytic adenovirus regulated by a radiation-inducible promoter selectively mediates hSulf-1 gene expression and mutually reinforces antitumor activity of I(131)-metuximab in hepatocellular carcinoma. Mol. Oncol. 2013, 7:346-358.
34. Lai J.P., Chien J.R., Moser D.R., Staub J.K., Aderca I., Montoya D.P., Matthews T.A., Nagorney D.M., Cunningham J.M., Smith D.I., Greene E.L., Shridhar V., Roberts L.R. HSulf1 Sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling. Gastroenterology 2004, 126:231-248.
35. Narita K., Staub J., Chien J., Meyer K., Bauer M., Friedl A., Ramakrishnan S., Shridhar V. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo. Cancer Res. 2006, 66:6025-6032.
36. Qian B., Katsaros D., Lu L., Preti M., Durando A., Arisio R., Mu L., Yu H. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1. Breast Cancer Res. Treat. 2009, 117:131-140.
37. Si M.L., Zhu S., Wu H., Lu Z., Wu F., Mo Y.Y. MiR-21-mediated tumor growth. Oncogene 2007, 26:2799-2803.
38. Tiwari N., Gheldof A., Tatari M., Christofori G. EMT as the ultimate survival mechanism of cancer cells. Semin. Cancer Biol. 2012, 22:194-207.
39. Ferraro A., Mourtzoukou D., Kosmidou V., Avlonitis S., Kontogeorgos G., Zografos G., Pintzas A. EZH2 is regulated by ERK/AKT and targets integrin alpha2 gene to control epithelial-mesenchymal Transition and anoikis in colon cancer cells. Int. J. Biochem. Cell Biol. 2012, 45:243-254.